Jeevan Scienti.

Jeevan_Scienti.03 May 2024

Healthcare

₹

-0.11 (-0.21%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Jeevan Scienti.

Jeevan Scienti.

Healthcare

Jeevan_Scienti.03 May 2024

₹

-0.11 (-0.21%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-May-2022	D	Board approved and recommended a dividend of 12% at the BM held on 30-May-2022	21-Sep-2022
23-Jun-2021	D	Board approves Dividend of Rs. 0.50/- per share subject to approval of shareholders.	07-Sep-2021
11-Mar-2024	BC	Resignation of Company Secretary and Compliance Officer	31-Mar-2024
01-Apr-2024	BC	Krishna Kishore Kuchipudi (Acquisition Dated on: 27/03/2024 to 28/03/2024	27-Mar-2024
27-Mar-2024	BC	Krishna Kishore Kuchipudi (Acquisition Dated on: 20/03/2024 to 22/03/2024)	20-Mar-2024
06-Feb-2024	BC	Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results	14-Feb-2024
04-Nov-2023	BC	Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve 1. Unaudited Financial resul	13-Nov-2023

No Rights has been declared by Jeevan_Scienti.

Book Closure

Record Date	Split Date	Purpose
31-Mar-2024	-	Resignation of Company Secretary and Compliance Officer
27-Mar-2024	-	Krishna Kishore Kuchipudi (Acquisition Dated on: 27/03/2024 to 28/03/2024
20-Mar-2024	-	Krishna Kishore Kuchipudi (Acquisition Dated on: 20/03/2024 to 22/03/2024)
14-Feb-2024	-	Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. Unaudited Financial results
13-Nov-2023	-	Jeevan Scientific Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2023 inter alia to consider and approve 1. Unaudited Financial resul

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Jeevan Scientific Technology Ltd ₹51.33(-0.11/-0.21%)	51.33	-0.11	79.63	-4.90	0.00	1.62
Kovai Medical Center & Hospital Ltd ₹3,977.40(-83.30/-2.05%)	3,977.40	-83.30	4,442.41	105.40	28.10	5.69
Shree Pacetronix Ltd ₹219.35(-11.50/-4.98%)	219.35	-11.50	83.09	89.22	21.24	7.33
Fortis Malar Hospitals Ltd ₹87.41(-1.78/-2.00%)	87.41	-1.78	167.16	79.96	0.00	2.93
Chennai Meenakshi Multispeciality Hospital Ltd ₹35.64(+0.13/0.37%)	35.64	+0.13	26.53	70.48	98.64	148.77
Apollo Hospitals Enterprise Ltd ₹6,009.00(+53.00/0.89%)	6,009.00	+53.00	85,638.14	32.88	85.76	11.74

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	10.13	8.06	10.39	7.93	9.95	7.97
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	10.13	8.06	10.39	7.93	9.95	7.97
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.12	0.26	0.30	0.26	0.28	0.31
Total Income	10.01	8.32	10.68	8.19	10.23	8.28
Total Expenditure	9.04	7.39	8.34	8.97	8.49	8.39
PBIDT	0.98	0.93	2.34	-0.78	1.74	-0.11
Interest	0.13	0.25	0.19	0.25	0.21	0.22
PBDT	0.85	0.68	2.15	-1.03	1.53	-0.33
Depreciation	1.35	1.38	1.42	1.37	1.34	1.26
Tax	-0.01	0.01	0.00	0.50	0.00	0.00
Deferred Tax	-0.10	-0.20	0.15	-0.64	0.14	-0.40
Reported Profit After Tax	-0.39	-0.50	0.58	-2.25	0.05	-1.19
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.39	-0.50	0.58	-2.25	0.05	-1.19

EPS (Unit Curr.)	-0.25	-0.32	0.38	-1.47	0.04	-0.83
EPS (Adj) (Unit Curr.)	-0.25	-0.32	0.38	-1.47	0.04	-0.83
Calculated EPS (Unit Curr.)	-0.25	-0.32	0.38	-1.45	0.04	-0.78
Calculated EPS (Adj) (Unit Curr.)	-0.25	-0.32	0.38	-1.45	0.04	-0.78
Calculated EPS (Ann.) (Unit Curr.)	-1.02	-1.30	1.51	-5.81	0.14	-3.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-1.02	-1.30	1.51	-5.81	0.14	-3.11
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	15.48	15.48	15.48	15.48	15.30	15.30
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	9.67	11.54	22.52	-9.84	17.49	-1.38
PBDTM(%)	8.39	8.44	20.69	-12.99	15.38	-4.14
PATM(%)	-3.85	-6.20	5.58	-28.37	0.50	-14.93

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	10.13	8.06	10.39	7.93	9.95	7.97
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	10.13	8.06	10.39	7.93	9.95	7.97
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	-0.11	0.26	0.30	0.27	0.28	0.31
Total Income	10.01	8.32	10.69	8.20	10.23	8.28
Total Expenditure	9.11	7.46	8.36	8.97	8.49	8.39
PBIDT	0.90	0.86	2.33	-0.77	1.74	-0.11
Interest	0.15	0.26	0.23	0.28	0.21	0.22
PBDT	0.75	0.60	2.10	-1.04	1.53	-0.33
Depreciation	1.40	1.43	1.47	1.42	1.34	1.26
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	-0.01	0.01	0.00	0.50	0.00	0.00
Deferred Tax	-0.15	-0.22	0.12	-0.65	0.14	-0.40
Reported Profit After Tax	-0.49	-0.61	0.51	-2.31	0.05	-1.19
Minority Interest After NP	-0.01	-0.01	-0.01	-0.01	0.00	0.00
Net Profit after Minority Interest	-0.48	-0.60	0.52	-2.30	0.05	-1.19

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.48	-0.60	0.52	-2.30	0.05	-1.19

EPS (Unit Curr.)	-0.31	-0.39	0.33	-1.51	0.04	-0.78
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	15.48	15.48	15.48	15.48	15.30	15.48

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	8.88	10.67	22.43	-9.71	17.49	-1.38
PBDTM(%)	7.40	7.44	20.21	-13.11	15.38	-4.14
PATM(%)	-4.84	-7.57	4.91	-29.13	0.50	-14.93

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	15.48	15.30	15.30	15.30	15.30	11.46
Reserves Total	32.84	35.28	20.95	9.63	17.47	8.11
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	3.13
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	48.32	50.58	36.25	24.93	32.77	22.70
Secured Loans	3.21	4.23	10.29	10.58	10.89	11.74
Unsecured Loans	5.63	8.32	0.05	7.37	7.26	7.04
Total Debt	8.84	12.55	10.34	17.95	18.15	18.78
Total Liabilities	57.16	63.13	46.59	42.88	50.92	41.48
APPLICATION OF FUNDS :
Gross Block	51.34	40.85	38.51	37.71	36.82	30.73
Less : Accumulated Depreciation	27.31	21.78	17.98	14.03	10.21	6.94
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	24.03	19.07	20.53	23.68	26.61	23.79
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.00	0.00	1.03	1.03	1.03	1.03
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.87	1.46	4.94	0.95	0.23	0.10
Sundry Debtors	11.68	7.61	12.46	6.00	14.51	16.12
Cash and Bank	6.12	29.71	5.68	1.88	3.66	1.37
Loans and Advances	9.27	15.11	7.87	7.85	6.20	2.84
Total Current Assets	27.95	53.89	30.96	16.68	24.59	20.44
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	6.28	9.02	15.12	9.43	8.85	7.57
Provisions	0.01	4.96	1.74	0.32	0.49	0.02
Total Current Liabilities	6.29	13.98	16.86	9.74	9.34	7.60
Net Current Assets	21.65	39.91	14.10	6.94	15.25	12.84
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.99	0.00	1.57	1.96	0.00	0.13
Deferred Tax Liability	0.35	0.50	0.97	0.38	0.38	0.24
Net Deferred Tax	0.64	-0.50	0.60	1.58	-0.38	-0.11
Total Assets	48.32	58.48	36.26	33.24	42.51	37.55
Contingent Liabilities	0.00	0.00	0.00	0.04	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	15.48	15.30	15.30	15.30	15.30	11.46
Reserves Total	32.71	35.28	19.72	7.92	16.53	7.42
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	3.13
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	48.19	50.58	35.02	23.22	31.83	22.01
Minority Interest	0.23	0.00	0.00	0.00	0.00	0.00
Secured Loans	3.51	4.23	10.29	10.58	10.89	11.74
Unsecured Loans	6.58	8.32	0.05	7.37	7.26	7.04
Total Debt	10.09	12.55	10.34	17.95	18.15	18.78
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.31	0.27	0.32	0.26	0.18	0.10
Total Liabilities	58.82	63.40	45.68	41.43	50.16	40.89
APPLICATION OF FUNDS :
Gross Block	52.33	40.85	45.39	44.75	42.15	35.21
Less: Accumulated Depreciation	27.35	21.78	18.02	14.21	9.55	7.04
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	24.98	19.07	27.37	30.54	32.60	28.17
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.90	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.87	1.46	3.46	0.95	0.23	0.10
Sundry Debtors	11.68	7.61	14.45	6.84	14.69	16.30
Cash and Bank	6.83	29.71	6.21	2.20	3.67	1.42
Loans and Advances	9.80	15.11	9.76	8.09	6.29	2.87
Total Current Assets	29.19	53.89	33.87	18.08	24.88	20.69
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.08	9.02	18.55	12.13	10.25	8.32
Provisions	0.01	4.96	1.74	0.32	0.49	0.02
Total Current Liabilities	7.09	13.98	20.29	12.44	10.74	8.34
Net Current Assets	22.10	39.91	13.58	5.63	14.14	12.35
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.00	0.00	1.56	1.96	0.00	0.12
Deferred Tax Liability	0.36	0.50	0.96	0.40	0.40	0.26
Net Deferred Tax	0.64	-0.50	0.60	1.56	-0.40	-0.14
Other Assets	9.22	4.92	4.13	3.69	3.83	0.51
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.04	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	29.71	5.68	1.88	3.66	1.37
Net Cash from Operating Activities	-8.77	19.56	4.73	-1.19	2.41
Net Cash Used In Investing Activities	-7.27	-1.20	-0.80	-1.02	-6.20
Net Cash Used In Financing Activities	-7.55	5.67	-0.13	0.44	6.07
Net Inc./Dec In Cash And Cash Equivalents	-23.59	24.03	3.80	-1.77	2.28
Cash And Cash Equivalents At End Of The Year	6.12	29.71	5.68	1.88	3.66

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

38.70%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

61.30%

**Promoter pledged shareholding 38.70%

About Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Ltd is in the Healthcare sector, having a market capitalization of Rs. 79.63 crores. It has reported a sales of Rs. 10.13 crores and a net profit of Rs. -0.39 crores for the quarter ended December 2018. The company management includes Koteswara Rao SSR, K Krishna Kishore,T Ravi Babu,G Bhanu Prakash,Koteswara Rao SSR,Snigdha Mothukuri,K. Jeevan Krishna,Sharvari Swapnil Shinde,Nageswar Rao Yarllagadda,G. Venkata Subba Rao,Divakar Atluri,B Suryaprakash Rao (Jeevan Scientific Technology Ltd) among others.

Chairman

Koteswara Rao SSR

Registered office

Plot 1 & 2 Sai Krupa Enclave,Manikonda Jagir Nr Lanco Hills,Hyderabad,Telangana,500008

FAX :91-40-67364707

Background

Incorporation Year1999

Face Value₹10

Market Lot1

How to buy Jeevan Scienti. shares on nse?

To buy Jeevan Scienti. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Jeevan Scienti. share price today?

The Jeevan Scienti. shares price on nse is Rs.51.33 today.

What is the market cap of Jeevan Scienti. shares on BSE ?

The company has a market capitalization of Rs.79.63Cr

What is the PE & PB ratio of Jeevan Scienti. shares ?

PE is 0 and PB is 1.62

What is the 52 Week High and Low of Jeevan Scienti. shares?

Jeevan Scienti. stock price high: Rs.70.94 Jeevan Scienti. stock price low: Rs.38.6